The gazette notification appoints individuals as Government Analysts at the National Institute of Biologicals (NIB), Noida, for specific classes of drugs. This appointment is made by the Central Government, exercising powers conferred by the Drugs and Cosmetics Act, 1940, and the Drugs Rules, 1945.
Key Changes
The notification supersedes previous notifications S.O. 4271(E) dated November 26, 2019, S.O. 2191(E) dated May 15, 2023, and G.S.R. 91(E) dated February 2, 2024, except for actions already taken or omitted before this supersession.
29 individuals are appointed as Government Analysts. Each analyst is assigned specific categories of drugs for which they will be responsible for analysis.
The analysts are appointed at the National Institute of Biologicals (NIB), Plot No. A-32, Sector 62, Institutional Area, Noida, Uttar Pradesh - 201309 and their jurisdiction extends to the whole of India.
The classes of drugs include In-vitro Diagnostic Medical Devices, Biochemical Kits, Molecular Diagnostic Kits, Blood Grouping Reagents, Blood Products (including recombinant origin), Recombinant products, Monoclonal Antibodies, Enzymes and Hormones (including recombinant origin), and Vaccines and Antisera.
Impact Analysis
Stakeholders
Government Analysts: The appointed individuals are directly impacted by this notification, as it defines their roles and responsibilities.
Suggested Action Items
Conduct training programs for the newly appointed analysts to keep them updated on the latest testing methodologies and regulatory requirements.
Key Entities Referenced
Drugs and Cosmetics Act, 1940: The principal legislation governing the import, manufacture, distribution, and sale of drugs and cosmetics in India.
Drugs Rule, 1945: Rules framed under the Drugs and Cosmetics Act, 1940, providing detailed procedures and requirements for various aspects of drug regulation.
National Institute of Biologicals (NIB): An autonomous institution under the Ministry of Health and Family Welfare, Government of India, responsible for quality control and standardization of biologicals.
S.O. 4271(E), dated November 26, 2019: Previous notification regarding the appointment of Government Analysts, now superseded by this notification.
S.O. 2191(E), dated May 15, 2023: Previous notification regarding the appointment of Government Analysts, now superseded by this notification.
G.S.R. 91(E), dated February 2, 2024: Previous notification regarding the appointment of Government Analysts, now superseded by this notification.
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99
सी.जी.-डी.एल.-अ.-30032025-262164
CG-DxLx-xEG-I3D0H0x3x2x0 25-262164
xxxGIDExxx
असाधारण
EXTRAORDINARY
भाग II—खण् ड 3—उप-खण्ड (i)
PART II—Section 3—Sub-section (i)
प्राजधकार स ेप्रकाजित
PUBLISHED BY AUTHORITY
स.ं 166] नई दिल्ली, बृहस्ट्प जतवार, मार् च27, 2025/र्त्रै 6, 1947
No. 166] NEW DELHI, THURSDAY, MARCH 27, 2025/CHAITRA 6, 1947
स्व ास््य और पररवार कल्य ाण मंत्रालय
(स्व ास््य और पररवार कल्य ाण ववभाग)
अविसचू ना
नई दिल्ली, 27 मार्च, 2025
का.आ. 203(अ).—केंद्रीय सरकार, ओषवि वनयम, 1945 के वनयम 44 के साथ परित ओषवि और प्रसािन
सामग्री अविवनयम, 1940 (1940 का 23) की िारा 20 की उपिारा (2) द्वारा प्रदत्त शवियों का प्रयोग करते हुए, और
भारत के राजपत्र, असािारण, भाग-II, खण्ड 3, उपखडं (ii) म ें संखयांक का. आ. 4271 (अ), तारीख 26 नवंबर, 2019,
का.अ. 2191 (अ), तारीख 15 मई, 2023 और सा. का. वन. 91 (अ). तारीख 2 फरवरी, 2024 म ें प्रकावशत भारत
सरकार के स्वास््य और पररवार कल्याण मंत्रालय की अविसचू ना को उन बातों के वसवाय, वजन्ह ें ऐसे अविक्रमण स े पूव व
ककया गया ह,ै या करन े का लोप ककया गया ह,ै उक्त सारणी के स्तंभ (3) म ें उनके नामों के सामन े वववनर्दवष्ट ओषवियों के
वगों के संबंि म ें संपूणव भारत के वलए, राष्रीय जैववक संस्थान, प्लॉट स.ं 32. सेक्टर 62, इंस्टीट्यूशनल एररया, नोएडा,
उत्तर प्रदेश-201909, म ें नीचे दी गई सारणी के स्तंभ (2) म ें वववनर्दवष्ट व्यवियों की वनयुवि सरकारी ववश्लेषक के रूप म ें
करती ह,ै अथावत ् :-
सारणी
क्रम स ं सरकारी ववश्लेषक का नाम ओषवियों का वग व
(1) (2) (3)
1 डॉ. आकांक्षा वबष्ट
2161 GI/2025 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
2 डॉ. राजेश कुमार शमा व इन-ववरो डायग्न ोवस्टक वचककत्सा उपकरण।
3 डॉ. ऋचा बरनवाल
4 डॉ. वरुण ससंह बायोकैवमकल कीटस
5 डॉ. गौरी वमश्रा मॉवलक्यूलर डायग्नोवस्टक कीटस
6 डॉ. अविनी कुमार दबु े
7 सुश्री कंचन आहूजा ब्लड ग्रुसपंग ररएजेंट्स
8 डॉ. पंकज कुमार शमाव
9 डॉ. मीना कुमारी
10 सुश्री वाई. मि ु ब्लड प्रोडक्टस, रींकॉम्बीनैंट मूल सवहत.
11 डॉ. मनोज कुमार
12 श्री तारा चंद
13 सुश्री सुिा वी गोपीनाथ
14 डॉ. चारु मेहरा कमल
15 सुश्री गुरसमंदर सबंद्रा रींकॉम्बीनैंट प्रोडक्ट्स
16 डॉ. संजय मेंदीरत्ता
17 सुश्री शावलनी वतवारी
18 डॉ. सुभाष चदं
19 डॉ. रत्नेश कुमार शमाव
मोनोक्लोनल एंटीबॉडी
20 डॉ. सौरभ शमाव
21 डॉ. हरीश चंदर
22 डॉ. ज्य ोवत शमाव
23 डॉ. हमे तं कुमार वमा व
24 श्री एन. नंदा गोपाल एंजाइम और हामोन, रींकॉम्बीनैंट मलू सवहत
25 सुश्री रवश्म श्रीवास्तव
26 श्री हररत कसाना
27 श्री जयपाल मीना वैक्स ीन और एंटीसेरा
28 डॉ. मंजलु ा ककरण
29 श्री नीरज मवलक
[फा.स.ं एक्स .11035/128/2024-डीआर]
राजीव विावन, सलाहकार (लागत)[भाग II—खण् ड 3(ii)] भारत का रािपत्र : असाधारण 3
MINISTRY OF HEALTH AND FAMILY WELFARE
(Department of Health and Family Welfare)
NOTIFICATION
New Delhi, the 27th March , 2025
S.O. 203(E).—In exercise of the powers conferred by sub-section (2) of section 20 of the Drugs and
Cosmetics Act, 1940 (23 of 1940) read with rule 44 of the Drugs Rule, 1945, and in supersession of the notification of
the Government of India in the Ministry of Health and Family Welfare numbers S.O. 4271(E), dated the 26th
November, 2019, S.O.2191(E), dated the 15th May, 2023 and G.S.R. 91(E), dated the 2nd February 2024 published in
Gazette of India, Extraordinary, Part II, Section 3, Sub-section (ii), except as respects things done or omitted to be
done before such supersession, the Central Government hereby appoints the persons specified in column (2) of the
Table below as Government Analysts at the National Institute of Biologicals, Plot No. A-32, Sector 62, Institutional
Area, Noida, Uttar Pradesh - 201309 for the whole of India in respect of the classes of drugs specified against their
names in column (3) of said Table, namely:—
Table
Class of Drugs
Sl. No Name of the Government Analyst
(3)
(1) (2)
1. Dr. Akanksha Bisht
2. Dr. Rajesh Kumar Sharma In-vitro Diagnostic Medical Devices.
3. Dr. Richa Baranwal
4. Dr. Varun Singh Biochemical Kits
5. Dr. Gauri Misra
Molecular Diagnostic Kits
6. Dr. Ashwini Kumar Dubey
7. Ms. Kanchan Ahuja
Blood Grouping Reagents.
8. Dr. Pankaj Kumar Sharma
9. Dr. Meena Kumari
10. Ms. Y. Madhu
11. Dr. Manoj Kumar Blood Products, including recombinant origin.
12. Mr. Tara Chand
13. Ms. Sudha V Gopinath
14. Dr. Charu Mehra Kamal
15. Ms. Gurminder Bindra
Recombinant products
16. Dr. Sanjay Mendiratta
17. Ms. Shalini Tewari
18. Dr. Subhash Chand
19. Dr. Ratnesh Kumar Sharma
20. Dr. Saurabh Sharma Monoclonal Antibodies
21. Dr. Harish Chander
22. Dr. Jyoti Sharma
23. Dr. Hemant Kumar Verma Enzymes and Hormones, including recombinant origin4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
24. Mr. N. Nanda Gopal
25. Ms. Rashmi Shrivastava
26. Mr. Harit Kasana
27. Mr. Jaipal Meena
Vaccine and Antisera.
28. Dr. Manjula Kiran
29. Mr. Neeraj Malik
[F.No. X.11035/128/2024-DR]
RAJIV WADHAWAN, Advisor(Cost)
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.